IMNM (STOCKS)
Immunome, Inc.
$26.400000
-1.590000 (-5.68%)
Prev close: $27.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Clay B. Siegall
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,650.16M
- Employees
- 155
- P/E (TTM)
- -11.08
- P/B (TTM)
- 6.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
14
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.48 | $-0.57 | +0.0936 | +16.32% |
|
Dec 2025 (Q4)
|
$-0.76 | $-0.61 | -0.1460 | -23.78% |
|
Sep 2025 (Q3)
|
$-0.65 | $-0.59 | -0.0643 | -10.98% |
|
Jun 2025 (Q2)
|
$-0.50 | $-0.54 | +0.0395 | +7.32% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $270.47M |
| Research and Development | $206.23M |
| Other Operating Expenses | $64.24M |
| Operating Income/Loss | -$270.47M |
| Income/Loss From Continuing Operations After Tax | -$254.32M |
| Income/Loss From Continuing Operations Before Tax | -$254.32M |
| Interest Income/Expense After Provision For Losses | $16.14M |
| Interest Income/Expense Operating, Net | $16.14M |
| Net Income/Loss | -$254.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$254.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$254.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$2.52 |
| Diluted Earnings Per Share | -$2.52 |
| Basic Average Shares | 203,689,786 |
| Diluted Average Shares | 203,689,786 |
| Assets | $565.38M |
| Current Assets | $538.45M |
| Noncurrent Assets | $26.94M |
| Fixed Assets | $17.36M |
| Other Non-current Assets | $9.58M |
| Liabilities | $40.30M |
| Current Liabilities | $35.71M |
| Accounts Payable | $6.00M |
| Wages | $6.17M |
| Other Current Liabilities | $23.55M |
| Noncurrent Liabilities | $4.59M |
| Equity | $525.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $525.08M |
| Liabilities And Equity | $565.38M |
| Net Cash Flow From Operating Activities | -$208.79M |
| Net Cash Flow From Operating Activities, Continuing | -$208.79M |
| Net Cash Flow From Investing Activities | -$196.48M |
| Net Cash Flow From Investing Activities, Continuing | -$196.48M |
| Net Cash Flow From Financing Activities | $479.11M |
| Net Cash Flow From Financing Activities, Continuing | $479.11M |
| Net Cash Flow | $73.83M |
| Net Cash Flow, Continuing | $73.83M |
| Comprehensive Income/Loss | -$254.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$254.63M |
| Other Comprehensive Income/Loss | -$57.77M |